| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aborted myocardial infarction: Is it real in the troponin era?
|
Vasile, Vlad C.
|
|
2009
|
157 |
4 |
p. 636-641
6 p.
|
artikel
|
| 2 |
Aldosterone and long-term outcome after myocardial infarction: A substudy of the french nationwide Observatoire sur la Prise en charge hospitalière, l'Evolution à un an et les caRactéristiques de patients présentant un infArctus du myocarde avec ou sans onde Q (OPERA) study
|
Beygui, Farzin
|
|
2009
|
157 |
4 |
p. 680-687
8 p.
|
artikel
|
| 3 |
Are we letting good stories obscure the truth—Can qualitative techniques provide clarification?
|
French, John K.
|
|
2009
|
157 |
4 |
p. 597-598
2 p.
|
artikel
|
| 4 |
Assessment of left ventricular dyssynchrony and function using real-time 3-dimensional echocardiography in patients with congenital right heart disease
|
Raedle-Hurst, Tanja M.
|
|
2009
|
157 |
4 |
p. 791-798
8 p.
|
artikel
|
| 5 |
Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy
|
Airan-Javia, Subha L.
|
|
2009
|
157 |
4 |
p. 687.e1-687.e8
6.8699993131E10 p.
|
artikel
|
| 6 |
Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: Data from the Women's Genome Health Study
|
Albert, Michelle A.
|
|
2009
|
157 |
4 |
p. 777-783.e1
7054 p.
|
artikel
|
| 7 |
Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction
|
Lambert, Nathan D.
|
|
2009
|
157 |
4 |
p. 688-694
7 p.
|
artikel
|
| 8 |
Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study
|
Han, Yaling
|
|
2009
|
157 |
4 |
p. 733-739
7 p.
|
artikel
|
| 9 |
Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
|
James, Stefan
|
|
2009
|
157 |
4 |
p. 599-605
7 p.
|
artikel
|
| 10 |
Correction
|
|
|
2009
|
157 |
4 |
p. 635-
1 p.
|
artikel
|
| 11 |
Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: Data from the Acorn trial
|
Park, Seong-Mi
|
|
2009
|
157 |
4 |
p. 762.e3-762.e10
7.619999238001E12 p.
|
artikel
|
| 12 |
Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus
|
Hage, Fadi G.
|
|
2009
|
157 |
4 |
p. 771-776
6 p.
|
artikel
|
| 13 |
Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: An experience-based review
|
Oudiz, Ronald J.
|
|
2009
|
157 |
4 |
p. 625-635
11 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2009
|
157 |
4 |
p. A6-
1 p.
|
artikel
|
| 15 |
Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study
|
Mak, Koon-Hou
|
|
2009
|
157 |
4 |
p. 658-665
8 p.
|
artikel
|
| 16 |
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry
|
Crespo, Eric M.
|
|
2009
|
157 |
4 |
p. 651-657
7 p.
|
artikel
|
| 17 |
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction
|
Goyal, Abhinav
|
|
2009
|
157 |
4 |
p. 763-770
8 p.
|
artikel
|
| 18 |
Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes
|
Tizón-Marcos, Helena
|
|
2009
|
157 |
4 |
p. 740-745
6 p.
|
artikel
|
| 19 |
Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: Analysis from the occluded artery trial
|
Cantor, Warren J.
|
|
2009
|
157 |
4 |
p. 666-672
7 p.
|
artikel
|
| 20 |
Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey
|
Kelley, Amy S.
|
|
2009
|
157 |
4 |
p. 702-708.e1
6379 p.
|
artikel
|
| 21 |
Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non–ST-elevation acute coronary syndromes undergoing diagnostic angiography
|
Wang, Tracy Y.
|
|
2009
|
157 |
4 |
p. 716-723
8 p.
|
artikel
|
| 22 |
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF
|
Yancy, Clyde W.
|
|
2009
|
157 |
4 |
p. 754-762.e2
75447 p.
|
artikel
|
| 23 |
Information for Authors
|
|
|
2009
|
157 |
4 |
p. A7-A8
nvt p.
|
artikel
|
| 24 |
Information for Readers
|
|
|
2009
|
157 |
4 |
p. A9-
1 p.
|
artikel
|
| 25 |
Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT)
|
Malek, Lukasz A.
|
|
2009
|
157 |
4 |
p. 724-732
9 p.
|
artikel
|
| 26 |
Letter to the Editor
|
Ratnayake, W.M.N.
|
|
2009
|
157 |
4 |
p. e23-
1 p.
|
artikel
|
| 27 |
Persistent reservations against contradicted percutaneous coronary intervention indications: Citation content analysis
|
Siontis, George C.M.
|
|
2009
|
157 |
4 |
p. 695-701
7 p.
|
artikel
|
| 28 |
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study
|
Byrne, Robert A.
|
|
2009
|
157 |
4 |
p. 620-624.e2
61781 p.
|
artikel
|
| 29 |
Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial
|
Shrank, William H.
|
|
2009
|
157 |
4 |
p. 613-619
7 p.
|
artikel
|
| 30 |
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
|
Becker, Matthew C.
|
|
2009
|
157 |
4 |
p. 606-612
7 p.
|
artikel
|
| 31 |
Response to Letter to the Editor by Block et al
|
Block, Robert
|
|
2009
|
157 |
4 |
p. e25-
1 p.
|
artikel
|
| 32 |
Response to letter-to-the-editor by Torres et al
|
Nguyen, Viviane
|
|
2009
|
157 |
4 |
p. e21-
1 p.
|
artikel
|
| 33 |
Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: Results from the Dallas Heart Study
|
de Lemos, James A.
|
|
2009
|
157 |
4 |
p. 746-753.e2
74555 p.
|
artikel
|
| 34 |
Table of Contents
|
|
|
2009
|
157 |
4 |
p. A1-A5
nvt p.
|
artikel
|
| 35 |
Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes
|
Rao, Rajeev V.
|
|
2009
|
157 |
4 |
p. 642-650.e1
5859 p.
|
artikel
|
| 36 |
The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project
|
Niu, Shaoli
|
|
2009
|
157 |
4 |
p. 709-715.e1
6442 p.
|
artikel
|
| 37 |
The challenge of the volume status assessment in heart failure
|
Parrinello, Gaspare
|
|
2009
|
157 |
4 |
p. e19-e20
nvt p.
|
artikel
|
| 38 |
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial
|
Truong, Quynh A.
|
|
2009
|
157 |
4 |
p. 673-679.e1
6118 p.
|
artikel
|
| 39 |
Use of a nurse-led intervention to optimize beta-blockade for reducing cardiac events after major noncardiac surgery
|
Marwick, Thomas H.
|
|
2009
|
157 |
4 |
p. 784-790
7 p.
|
artikel
|
Tijdschrift beschrijving